Pioglitazone Reduces Dementia Risk in Patients with Type 2 Diabetes Mellitus: A Retrospective Cohort Analysis

about

Pioglitazone Reduces Dementia Risk in Patients with Type 2 Diabetes Mellitus: A Retrospective Cohort Analysis

Item

http://www.wikidata.org/entity/Q59127002

description

scientific article published on 27 September 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована у вересні 2018

@uk

name

Pioglitazone Reduces Dementia ...... Retrospective Cohort Analysis

@en

Pioglitazone Reduces Dementia ...... Retrospective Cohort Analysis

@nl

type

Item

label

Pioglitazone Reduces Dementia ...... Retrospective Cohort Analysis

@en

Pioglitazone Reduces Dementia ...... Retrospective Cohort Analysis

@nl

prefLabel

Pioglitazone Reduces Dementia ...... Retrospective Cohort Analysis

@en

Pioglitazone Reduces Dementia ...... Retrospective Cohort Analysis

@nl

P1476

Pioglitazone Reduces Dementia ...... Retrospective Cohort Analysis

@en

P2093

Chin-Hsiao Tseng

http://www.w3.org/2001/XMLSchema#string

P2860

Metabolic Alterations Associated to Brain Dysfunction in Diabetes

Link between type 2 diabetes and Alzheimer's disease: from epidemiology to mechanism and treatment

Influence of drug transporters and stereoselectivity on the brain penetration of pioglitazone as a potential medicine against Alzheimer's disease

η-Secretase processing of APP inhibits neuronal activity in the hippocampus.

Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies.

Neuroinflammation impairs adaptive structural plasticity of dendritic spines in a preclinical model of Alzheimer's disease.

Pioglitazone after Ischemic Stroke or Transient Ischemic Attack.

The PPARγ agonist pioglitazone crosses the blood-brain barrier and reduces tumor growth in a human xenograft model.

Ginsenoside Rg1 attenuates β-amyloid generation via suppressing PPARγ-regulated BACE1 activity in N2a-APP695 cells.

MH84: A Novel γ-Secretase Modulator/PPARγ Agonist--Improves Mitochondrial Dysfunction in a Cellular Model of Alzheimer's Disease.

P304

306

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3390/JCM7100306

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Chin-Hsiao Tseng

P577

2018-09-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30262775

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

P932

6209987

http://www.w3.org/2001/XMLSchema#string